Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://elodieaehz661918.fitnell.com/79811671/semaglutide-a-potential-solution-for-diabetes